Skip to content

NPNKF

Nippon Shinyaku Co.,Ltd.

医薬品 · 医薬品 · JP

Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue166.0B170.8B160.2B148.3B144.2B
Cost of Revenue12.7B57.5B51.1B50.2B56.0B
Gross Profit26.9B113.3B109.1B98.0B88.2B
Operating Expenses
R&D Expense
SG&A Expense10.0B43.6B38.0B35.0B34.8B
General & Admin Expense
Selling & Marketing Expense
Other Expenses794.0M560.0M2.2B1.3B1.1B
Total Operating Expenses10.8B44.1B40.2B36.2B35.9B
Cost and Expenses131.0B135.3B124.8B115.0B114.1B
Operating Income (EBIT)35.0B35.5B35.5B33.3B30.0B
Non-Operating
Interest Income468.0M1.1B830.0M650.0M575.0M
Interest Expense46.0M166.0M145.0M329.0M136.0M
Net Interest Income422.0M966.0M685.0M321.0M439.0M
Other Non-Op Income/Expense169.0M3.0B874.0M3.2B1.9B
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)10.5B36.5B36.1B33.6B30.5B
Income Tax Expense2.2B6.7B3.6B7.8B7.7B
Bottom Line
Net Income29.9B29.7B32.6B25.9B22.8B
Earnings from Cont. Ops
Earnings from Discont. Ops
Bottom Line Net Income29.9B29.7B32.6B25.9B22.8B
Per Share
Basic EPS$443.13$441.25$483.40$383.82$338.70
Diluted EPS$443.13$441.25$483.26
Revenue Per Share$2,465.23$2,535.34$2,379.00$2,201.17$2,140.59
Shares
Basic Shares Outstanding67.4M67.4M67.4M67.4M67.4M
Diluted Shares Outstanding
Profitability Metrics
EBITDA11.7B42.1B41.5B38.3B35.1B
D&A1.6B6.6B6.0B5.0B5.0B
EBIT35.0B35.5B35.5B33.3B30.0B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026